Syngene International Balance Sheet Health
Financial Health criteria checks 6/6
Syngene International has a total shareholder equity of ₹42.6B and total debt of ₹1.4B, which brings its debt-to-equity ratio to 3.3%. Its total assets and total liabilities are ₹61.5B and ₹18.9B respectively. Syngene International's EBIT is ₹6.4B making its interest coverage ratio 20.5. It has cash and short-term investments of ₹10.8B.
Key information
3.3%
Debt to equity ratio
₹1.42b
Debt
| Interest coverage ratio | 20.5x |
| Cash | ₹10.77b |
| Equity | ₹42.58b |
| Total liabilities | ₹18.94b |
| Total assets | ₹61.52b |
Recent financial health updates
These 4 Measures Indicate That Syngene International (NSE:SYNGENE) Is Using Debt Safely
Mar 28
Is Syngene International (NSE:SYNGENE) A Risky Investment?
Nov 19Syngene International (NSE:SYNGENE) Seems To Use Debt Rather Sparingly
Aug 07These 4 Measures Indicate That Syngene International (NSE:SYNGENE) Is Using Debt Safely
Apr 28Syngene International (NSE:SYNGENE) Has A Pretty Healthy Balance Sheet
Dec 08Is Syngene International (NSE:SYNGENE) Using Too Much Debt?
Aug 28Recent updates
These 4 Measures Indicate That Syngene International (NSE:SYNGENE) Is Using Debt Safely
Mar 28Do Syngene International's (NSE:SYNGENE) Earnings Warrant Your Attention?
Feb 14Earnings Not Telling The Story For Syngene International Limited (NSE:SYNGENE)
Jan 19Is Syngene International (NSE:SYNGENE) A Risky Investment?
Nov 19Is Now The Time To Put Syngene International (NSE:SYNGENE) On Your Watchlist?
Nov 01Syngene International (NSE:SYNGENE) Seems To Use Debt Rather Sparingly
Aug 07These 4 Measures Indicate That Syngene International (NSE:SYNGENE) Is Using Debt Safely
Apr 28Here's Why We Think Syngene International (NSE:SYNGENE) Is Well Worth Watching
Apr 06Does Syngene International (NSE:SYNGENE) Deserve A Spot On Your Watchlist?
Jan 04Syngene International (NSE:SYNGENE) Has A Pretty Healthy Balance Sheet
Dec 08Is Syngene International (NSE:SYNGENE) Using Too Much Debt?
Aug 28Syngene International Limited (NSE:SYNGENE) Shares Could Be 22% Above Their Intrinsic Value Estimate
Aug 10These 4 Measures Indicate That Syngene International (NSE:SYNGENE) Is Using Debt Reasonably Well
May 10Does Syngene International (NSE:SYNGENE) Have A Healthy Balance Sheet?
Feb 02Does Syngene International (NSE:SYNGENE) Deserve A Spot On Your Watchlist?
Nov 26Here's Why Syngene International (NSE:SYNGENE) Can Manage Its Debt Responsibly
Sep 21Here's Why I Think Syngene International (NSE:SYNGENE) Is An Interesting Stock
Aug 06The CEO Of Syngene International Limited (NSE:SYNGENE) Might See A Pay Rise On The Horizon
Jul 14Is Syngene International (NSE:SYNGENE) A Risky Investment?
Jun 09We Think Syngene International (NSE:SYNGENE) Can Stay On Top Of Its Debt
Feb 18Syngene International Limited Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next
Jan 23
Financial Position Analysis
Short Term Liabilities: SYNGENE's short term assets (₹19.6B) exceed its short term liabilities (₹11.4B).
Long Term Liabilities: SYNGENE's short term assets (₹19.6B) exceed its long term liabilities (₹7.5B).
Debt to Equity History and Analysis
Debt Level: SYNGENE has more cash than its total debt.
Reducing Debt: SYNGENE's debt to equity ratio has reduced from 41% to 3.3% over the past 5 years.
Debt Coverage: SYNGENE's debt is well covered by operating cash flow (735.4%).
Interest Coverage: SYNGENE's interest payments on its debt are well covered by EBIT (20.5x coverage).